1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
Quest Diagnostics Incorporated

Quest Diagnostics Incorporated

DGX
Quest Diagnostics IncorporatedUS flagNew York Stock Exchange
237.14
USD
-2.26
- -
26.17BMarket Cap

Total Valuation

Quest Diagnostics Incorporated carries a market capitalization of 26.17B, placing it among publicly traded companies globally. Its enterprise value stands at 29.39B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap26.17B
Enterprise Value29.39B

Share Statistics

Quest Diagnostics Incorporated currently has 109.70M shares outstanding.

Shares Outstanding109.70M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Quest Diagnostics Incorporated trades at a trailing price-to-earnings ratio of 22.15. The price-to-sales ratio is 2.04, and the price-to-book ratio stands at 3.09.

PE Ratio22.15
PS Ratio2.04
PB Ratio3.09
P/TBV Ratio-7.11
P/FCF Ratio12.50
P/OCF Ratio12.36

Enterprise Valuation

On an enterprise value basis, Quest Diagnostics Incorporated trades at an EV/EBITDA multiple of 13.27 and an EV/FCF ratio of 13.92. The EV/Sales ratio of 2.54 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 17.98 provides insight into valuation relative to core operating earnings.

EV / Sales2.54
EV / EBITDA13.27
EV / EBIT17.98
EV / FCF13.92

Financial Position

Quest Diagnostics Incorporated maintains a current ratio of 1.59, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 80.81, indicating elevated leverage, while an interest coverage ratio of 8.23 demonstrates adequate ability to service its debt obligations.

Current Ratio1.59
Quick Ratio1.28
Debt / Equity80.81
Debt / EBITDA2.88
Interest Coverage8.23

Financial Efficiency

Quest Diagnostics Incorporated posts a return on equity of 14.41 and a return on invested capital of 9.03.

Return on Equity (ROE)14.41
Return on Assets (ROA)6.45
Return on Invested Capital (ROIC)9.03
Return on Capital Employed (ROCE)8.70
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover36.82

Taxes

Over the trailing twelve months, Quest Diagnostics Incorporated has paid 320.00M in income taxes, reflecting an effective tax rate of 22.79.

Income Tax320.00M
Effective Tax Rate22.79

Stock Price Statistics

Quest Diagnostics Incorporated's stock has gained approximately 31.66398% over the past 52 weeks. The 50-day moving average sits at 226.92, while the 200-day moving average is 200.83.

Beta (5Y)N/A
52-Week Price Change31.66398%
50-Day Moving Average226.92
200-Day Moving Average200.83
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Quest Diagnostics Incorporated generated 11.56B in revenue and converted that into 1.06B in net income, yielding earnings per share of 9.92. EBITDA reached 2.22B, while operating income came in at 1.64B.

Revenue11.56B
Gross Profit3.83B
Operating Income1.64B
Pretax Income1.40B
Net Income1.06B
EBITDA2.22B
EBIT1.64B
Earnings Per Share (EPS)9.92

Balance Sheet

Quest Diagnostics Incorporated holds 626.00M in cash and equivalents against 6.38B in total debt, resulting in a net debt position of 5.02B. Total book value stands at 7.52B, with working capital of 1.06B providing operational flexibility.

Cash & Cash Equivalents626.00M
Total Debt6.38B
Net Debt5.02B
Equity (Book Value)7.52B
Book Value Per Share68.52
Working Capital1.06B

Cash Flow

Quest Diagnostics Incorporated produced 1.90B in operating cash flow over the past twelve months.

Operating Cash Flow1.90B
Capital ExpendituresN/A
Free Cash Flow1.90B
FCF Per Share17.14

Margins

Quest Diagnostics Incorporated operates with a gross margin of 33.11, reflecting its pricing power and cost economics. The operating margin of 14.14 and net profit margin of 9.19 provide insight into operational efficiency.

Gross Margin33.11
Operating Margin14.14
Pretax Margin12.15
Profit Margin9.19
EBITDA Margin19.16

Dividends & Yields

The company's payout ratio of 31.19 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share3.27
Dividend YieldN/A
Payout Ratio31.19
Shareholder Yield3.94
FCF Yield8.00

Stock Splits

Quest Diagnostics Incorporated's most recent stock split took place on June 21, 2005 with a 1:2 split ratio.

Last Split Date6/21/2005
Split Ratio1:2

Scores

Quest Diagnostics Incorporated posts an Altman Z-Score of 6.86, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score6.86